Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ENDRA Life Sciences Inc. - Common Stock (NQ:NDRA)

5.330 -0.170 (-3.09%)
Streaming Delayed Price Updated: 11:55 AM EST, Dec 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about ENDRA Life Sciences Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
ENDRA Life Sciences (NASDAQ: NDRA) Advances TAEUS® Liver Imaging, Strengthens Capital Efficiency; WVE, TWG, BDRX, FULC Also Active
Via AB Newswire
News headline image
Polyrizon (NASDAQ: PLRZ) Soars as Superior Mucoadhesion Naloxone Hydrogel Signals Stronger Real-World Opioid Overdose Reversal Potential
Via AB Newswire
Topics Artificial Intelligence Death
News headline image
ENDRA’s TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences (NASDAQ: NDRA) Advances Treasury Flywheel and TAEUS® Liver Imaging Platform
Via AB Newswire
News headline image
Datavault AI (NASDAQ: DVLT) Licenses Healthcare IP to Wellgistics Health (NASDAQ: WGRX); Bonus Stocks in the News This Week TOON, NDRA, PRSO, RDZN more inside
Via AB Newswire
Topics Artificial Intelligence Economy Intellectual Property
News headline image
ENDRA Life Sciences (NASDAQ: NDRA) Advances “Yield-to-Innovation” Strategy to Accelerate Breakthrough Liver Imaging Technology
Via AB Newswire
News headline image
ENDRA Feasibility Study Demonstrates TAEUS® Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
The New Era of Treasury Strategy: ENDRA Life Sciences (NASDAQ: NDRA) Impacting Healthcare
Via AB Newswire
News headline image
ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences Inc. (NASDAQ: NDRA) Digital Asset Tokenization to Drive Long-Term Shareholder Value
Via AB Newswire
News headline image
ENDRA Life Sciences Commences Staking of HYPE Digital Asset Holdings, Reinforcing Long-Term Strategy with Anchorage Digital and ARCA
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
TOMI Environmental (NASDAQ: TOMZ) | Norovirus Strain Shift Exposes Urgent Need for Next-Generation Disinfection
Via AB Newswire
Topics Artificial Intelligence
News headline image
ENDRA Life Sciences Closes Up to $14.4 Million Private Placement and Launches Crypto Treasury Strategy with $3 Million in Initial HYPE Token Holdings
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences Announces At-Market Private Placement of Up to $14.4 Million to Launch Digital Asset Treasury Strategy Managed by Leading Crypto Asset Manager Arca
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences Provides a Business Update and Reports Second Quarter 2025 Financial Results
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
MAG 7 Undercard: $5 Stocks to Watch – NDRA, BSLK, WOLF, OCC, SNYR Poised for Action More Inside
Via AB Newswire
News headline image
ENDRA’s Ongoing Multisite Pilot Study Reveals Important Enhancements to Boost TAEUS Liver Accuracy and Repeatability Against MRI Gold Standard
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences Provides a Business Update and Reports First Quarter 2025 Financial Results
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences Announces Enhanced Strategy to Enable the Early Detection and Management of Metabolic Diseases Facilitated by Emerging GLP-1 Therapies
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
Study Highlighting ENDRA Life Sciences’ TAEUS Technology in Patients with High BMI to be Presented at AASLD’s The Liver Meeting® 2024
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European Patent
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences Announces Reverse Stock Split
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences Reschedules Second Quarter Conference Call to August 22, 2024
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences Announces Leadership Changes
From ENDRA Life Sciences Inc.
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.